London, W1G 9RT,
United Kingdom
Akari Therapeutics, Plc Technographics
Akari Therapeutics, Plc Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Akari Therapeutics, Plc and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 Akari Therapeutics, Plc employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Akari Therapeutics, Plc has purchased the following applications: Microsoft 365 for Collaboration in 2015, Intuit Mailchimp for Marketing Automation in 2017, Ionic Platform for Apps Development in 2017 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Akari Therapeutics, Plc is running and its propensity to invest more and deepen its relationship with Microsoft , Intuit , Ionic or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Akari Therapeutics, Plc revenues, which have grown to $2.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Akari Therapeutics, Plc intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Akari Therapeutics, Plc Tech Stack and Enterprise Applications
Akari Therapeutics, Plc Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 Akari Therapeutics, Plc implemented Microsoft 365. Akari Therapeutics, Plc implemented Microsoft 365 as a Collaboration platform to support corporate communications and website content, and public site metadata indicates Microsoft 365 is used on their website. This establishes Microsoft 365 as the primary cloud collaboration layer for the small UK life sciences firm.
Deployment is expected to leverage core Collaboration capabilities such as Exchange Online for email, SharePoint Online for site and document hosting, OneDrive for personal file synchronization, and Microsoft Teams for synchronous collaboration. Administration and governance are concentrated within the small corporate team, with configuration focused on account provisioning, access control, and content publishing workflows. The implementation supports business functions including corporate communications, research team collaboration, and document management for the ten employee company.
|
Akari Therapeutics, Plc CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Intuit | Legacy | Intuit Mailchimp | Marketing Automation | CRM | n/a | 2017 | 2017 |
In 2017, Akari Therapeutics, Plc deployed Intuit Mailchimp as its Marketing Automation solution. Intuit Mailchimp is implemented on Akari Therapeutics' website to capture subscribers through embedded signup forms and to power email campaign distribution and tracking. The implementation reflects Marketing Automation use cases such as audience list management, campaign scheduling, and basic engagement analytics.
Configuration and operational scope are proportionate to a 10 employee life sciences firm, with Mailchimp supporting corporate marketing and investor communications in the United Kingdom. Functional emphasis includes web-to-list workflows, template-driven email sends, audience segmentation and automated campaign flows consistent with Marketing Automation capabilities. Governance and process control appear centered on centralized account administration, campaign approval workflows and web form maintenance to ensure consistent subscriber capture and compliance.
|
Akari Therapeutics, Plc PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Ionic | Legacy | Ionic Platform | Apps Development | PaaS | n/a | 2017 | 2017 |
In 2017, Akari Therapeutics, Plc implemented Ionic Platform for Apps Development on its public website. The deployment used Ionic Platform to provide a consistent front end delivery layer for web content and interactive pages, leveraging Apps Development capabilities such as reusable UI components, responsive layout patterns, and client side application bundling.
Implementation scope was focused on the company website, with Ionic Platform serving as the primary front end framework for external pages and digital engagement flows. Governance and operational ownership remained with Akari Therapeutics' web operations, with configuration centered on component libraries, routing, and asset optimization consistent with Apps Development workflows, and ongoing updates incorporated into the website release cycle.
|
Akari Therapeutics, Plc IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
IT Decision Makers and Key Stakeholders at Akari Therapeutics, Plc
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Akari Therapeutics, Plc Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||